NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/04/2022
Back to search
Official data from USPTO
AMPLIDEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/04/2022
Trademark type
Word
Nice classes
5
Filing date
06/28/2010
Registration date
10/25/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2022
Last transaction
03/04/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/16/2010
First use in commerce
08/16/2010
Drawing code
4
Owner type
03
Owner location
Austin, TX, US
Examiner
SERVANCE, RENEE L
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Asuragen, Inc.
Representatives
Courtney Thompson Fredrikson & Byron, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic kits consisting primarily of diagnostic reagents and instructions sold as a unit for medical diagnostic uses
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/04/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/04/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/04/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
10/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/04/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/25/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/18/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/18/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/18/2018
E815
TEAS SECTION 8 & 15 RECEIVED
04/09/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/25/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
10/25/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/21/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/20/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/19/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/25/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/25/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/25/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/31/2011
GNRT
NON-FINAL ACTION E-MAILED
05/31/2011
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/31/2011
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/19/2011
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/18/2011
IUAF
USE AMENDMENT FILED
05/13/2011
EISU
TEAS STATEMENT OF USE RECEIVED
05/13/2011
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/29/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/01/2011
PUBO
PUBLISHED FOR OPPOSITION
02/01/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/30/2010
ALIE
ASSIGNED TO LIE
12/30/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/28/2010
GNRT
NON-FINAL ACTION E-MAILED
09/28/2010
CNRT
NON-FINAL ACTION WRITTEN
09/28/2010
DOCK
ASSIGNED TO EXAMINER
09/27/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2010
NWAP
NEW APPLICATION ENTERED
07/01/2010
Continuous trademark protection
Get notified about every new filing that threatens AMPLIDEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.